5-nitro-2-(1,3-oxazol-2-yl)-3,4'-bipyridin-6-amine 在
钯乙醚 作用下,
以
乙醇 为溶剂,
反应 3.0h,
以Trituration with diethyl ether gave the title compound (0.077 g, 97%) as a pale orange solid的产率得到2-(1,3-oxazol-2-yl)-3,4'-bipyridin-5,6-diamine
参考文献:
名称:
Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
申请人:Vidal Juan Bernat
公开号:US20080275038A1
公开(公告)日:2008-11-06
The present disclosure relates to imidazopyridine derivatives of formula (I):
The present disclosure also relates to a method for treating a subject afflicted with a pathological condition or disease susceptible to amelioration by antagonism of the A
2B
adenosine receptor.
IMIDAZOPYRIDINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS
申请人:Laboratorios Almirall, S.A.
公开号:EP1931666A1
公开(公告)日:2008-06-18
US7855202B2
申请人:——
公开号:US7855202B2
公开(公告)日:2010-12-21
[EN] IMIDAZOPYRIDINE DERIVATIVES AS A2B ADENOSINE RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS D'IMIDAZOPYRIDINE EN TANT QU'ANTAGONISTES DU RÉCEPTEUR A2B DE L'ADÉNOSINE
申请人:ALMIRALL LAB
公开号:WO2007039297A1
公开(公告)日:2007-04-12
[EN] New imidazopyrdidine derivatives of formula (I) are disclosed as antagonists of the A28 adenosine receptor. [FR] La présente invention porte sur de nouveaux dérivés d'imidazopyridine de formule (I) en tant qu'antagonistes du récepteur A2B de l'adénosine.